These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 33083449)
21. Potential targets and molecular mechanism of miR-331-3p in hepatocellular carcinoma identified by weighted gene coexpression network analysis. Chi Q; Geng X; Xu K; Wang C; Zhao H Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32537629 [TBL] [Abstract][Full Text] [Related]
22. The Role of Long Non-Coding RNA and microRNA Networks in Hepatocellular Carcinoma and Its Tumor Microenvironment. Shi T; Morishita A; Kobara H; Masaki T Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638971 [TBL] [Abstract][Full Text] [Related]
23. Four Autophagy-Related lncRNAs Predict the Prognosis of HCC through Coexpression and ceRNA Mechanism. Wu H; Liu T; Qi J; Qin C; Zhu Q Biomed Res Int; 2020; 2020():3801748. PubMed ID: 33102579 [TBL] [Abstract][Full Text] [Related]
24. Four long noncoding RNAs as potential prognostic biomarkers for hepatocellular carcinoma. Wang J; Pu J; Yao T; Lu X; Deng Y J Cell Physiol; 2019 Jun; 234(6):8709-8716. PubMed ID: 30417366 [TBL] [Abstract][Full Text] [Related]
25. Construction of a long non-coding RNA-associated ceRNA network reveals potential prognostic lncRNA biomarkers in hepatocellular carcinoma. Yan Y; Yu J; Liu H; Guo S; Zhang Y; Ye Y; Xu L; Ming L Pathol Res Pract; 2018 Dec; 214(12):2031-2038. PubMed ID: 30316688 [TBL] [Abstract][Full Text] [Related]
26. Molecular mechanisms of circular RNAs, transforming growth factor-β, and long noncoding RNAs in hepatocellular carcinoma. Shang W; Adzika GK; Li Y; Huang Q; Ding N; Chinembiri B; Rashid MS; Machuki JO Cancer Med; 2019 Nov; 8(15):6684-6699. PubMed ID: 31523930 [TBL] [Abstract][Full Text] [Related]
27. Bioinformatics analysis of different candidate genes involved in hepatocellular carcinoma induced by HepG2 cells or tumor cells of patients. Zhang X; Yin S; Ma K J Int Med Res; 2020 Jun; 48(6):300060520932112. PubMed ID: 32567431 [TBL] [Abstract][Full Text] [Related]
28. A 9‑lncRNA risk score system for predicting the prognosis of patients with hepatitis B virus‑positive hepatocellular carcinoma. Liu H; Zhao P; Jin X; Zhao Y; Chen Y; Yan T; Wang J; Wu L; Sun Y Mol Med Rep; 2019 Jul; 20(1):573-583. PubMed ID: 31115573 [TBL] [Abstract][Full Text] [Related]
29. Five lncRNAs associated with the survival of hepatocellular carcinoma: a comprehensive study based on WGCNA and competing endogenous RNA network. Liu DH; Wang SL; Hua Y; Shi GD; Qiao JH; Wei H Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7621-7633. PubMed ID: 32744688 [TBL] [Abstract][Full Text] [Related]
30. Co-expression network analysis identified six hub genes in association with metastasis risk and prognosis in hepatocellular carcinoma. Chen P; Wang F; Feng J; Zhou R; Chang Y; Liu J; Zhao Q Oncotarget; 2017 Jul; 8(30):48948-48958. PubMed ID: 28430663 [TBL] [Abstract][Full Text] [Related]
31. LncRNA ROR1‑AS1 high expression and its prognostic significance in liver cancer. Zhang Z; Wang S; Yang F; Meng Z; Liu Y Oncol Rep; 2020 Jan; 43(1):55-74. PubMed ID: 31746401 [TBL] [Abstract][Full Text] [Related]
32. Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma. Mou Y; Wang D; Xing R; Nie H; Mou Y; Zhang Y; Zhou X Cancer Biomark; 2018; 23(1):95-106. PubMed ID: 29991128 [TBL] [Abstract][Full Text] [Related]
33. Long Non-Coding RNAs as Mediators of Tumor Microenvironment and Liver Cancer Cell Communication. Lin YH; Wu MH; Yeh CT; Lin KH Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30477236 [TBL] [Abstract][Full Text] [Related]
34. Long noncoding RNA TCL6 binds to miR-106a-5p to regulate hepatocellular carcinoma cells through PI3K/AKT signaling pathway. Luo LH; Jin M; Wang LQ; Xu GJ; Lin ZY; Yu DD; Yang SL; Ran RZ; Wu G; Zhang T J Cell Physiol; 2020 Sep; 235(9):6154-6166. PubMed ID: 32020591 [TBL] [Abstract][Full Text] [Related]
35. Comparative analysis of hepatocellular carcinoma and cirrhosis gene expression profiles. Jiang M; Zeng Q; Dai S; Liang H; Dai F; Xie X; Lu K; Gao C Mol Med Rep; 2017 Jan; 15(1):380-386. PubMed ID: 27959423 [TBL] [Abstract][Full Text] [Related]
36. LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signaling. Liu J; Xu R; Mai SJ; Ma YS; Zhang MY; Cao PS; Weng NQ; Wang RQ; Cao D; Wei W; Guo RP; Zhang YJ; Xu L; Chen MS; Zhang HZ; Huang L; Fu D; Wang HY Theranostics; 2020; 10(17):7527-7544. PubMed ID: 32685003 [TBL] [Abstract][Full Text] [Related]
37. Identification of Hepatocellular Carcinoma-Related Potential Genes and Pathways Through Bioinformatic-Based Analyses. Wan Z; Zhang X; Luo Y; Zhao B Genet Test Mol Biomarkers; 2019 Nov; 23(11):766-777. PubMed ID: 31633428 [No Abstract] [Full Text] [Related]
38. Comprehensive analysis of five long noncoding RNAs expression as competing endogenous RNAs in regulating hepatoma carcinoma. Lou X; Li J; Yu D; Wei YQ; Feng S; Sun JJ Cancer Med; 2019 Sep; 8(12):5735-5749. PubMed ID: 31392826 [TBL] [Abstract][Full Text] [Related]
39. Comprehensive analyses of competing endogenous RNA networks reveal potential biomarkers for predicting hepatocellular carcinoma recurrence. Yan P; Huang Z; Mou T; Luo Y; Liu Y; Zhou B; Cao Z; Wu Z BMC Cancer; 2021 Apr; 21(1):436. PubMed ID: 33879119 [TBL] [Abstract][Full Text] [Related]